Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072511 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation Intervention
A Phase 4 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT03072511 is a Phase 4 study that was terminated before completion, run by University of Florida. The registered enrollment target is 23 participants.
The verdict
NCT03072511, a Phase 4 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
Cigarette smoking is the leading cause of preventable mortality in the United States, yet less than 10% of smokers making a serious quit attempt remain abstinent from cigarettes 1 year later, and outcomes from gold-standard behavioral interventions leave much room for improvement. As such, in the context of a Stage-I randomized controlled trial (RCT), this study will examine (1) treatment characteristics and delivery, treatment integrity, dropout, and acceptability, (2) smoking outcomes such as lapse, relapse, and abstinence measures, and (3) changes decision-making that result from a novel intervention informed by behavioral analysis and social cognition.
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL Spotlight on Smoke-Free Living: Mindsets and Decisions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-12-13 |
| Est. Completion | 2018-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03072511
The ClinicalTrials.gov registry entry for NCT03072511 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT03072511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03072511 about?
NCT03072511 is a clinical study titled "Smoking Cessation Intervention". Cigarette smoking is the leading cause of preventable mortality in the United States, yet less than 10% of smokers making a serious quit attempt remain abstinent from cigarettes 1 year later, and outcomes from gold-standard behavioral interventions leave much room for improvement. As such, in the co...
What is the current status of trial NCT03072511?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2016-12-13. Estimated completion is 2018-08-01.
What interventions are being tested in trial NCT03072511?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Spotlight on Smoke-Free Living: Mindsets and Decisions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03072511?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.